+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene



Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene



British Journal of Dermatology 163(3): 487-494



Oculocutaneous albinism (OCA) refers to a group of inherited disorders where the patients have little or no pigment in the eyes, skin and hair. Mutations in genes regulating multi-step melanin biosynthesis are the basis of four 'classical' OCA types with overlapping clinical features. There are a few reports on defects in TYR and a single report on SLC45A2 in Indians affected with OCA but no report on OCA2 (a major locus related to the disease) and TYRP1. To assess and describe a comprehensive picture of the molecular genetic basis of OCA among Indians with no apparent mutations in TYR. Twenty-four affected pedigrees from 14 different ethnicities were analysed for mutations in OCA2, TYRP1, SLC45A2 and SLC24A5 using the polymerase chain reaction-sequencing approach. Two splice-site and four missense mutations were detected in OCA2 in seven unrelated pedigrees, including four novel mutations. Haplotype analysis revealed a founder mutation (Ala787Thr) in two unrelated families of the same ethnicity. A patient homozygous for a novel SLC45A2 mutation also harboured a novel OCA2 defect. No mutation was detected in TYRP1 or SLC24A5. Our results suggest that an OCA2 gene defect is the second most prevalent type of OCA in India after TYR. The presence of homozygous mutations in the affected pedigrees underscores the lack of intermixing between the affected ethnicities. Direct detection of the genetic lesions prevalent in specific ethnic groups could be used for carrier detection and genetic counselling to contain the disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269904

Download citation: RISBibTeXText

PMID: 20426782

DOI: 10.1111/j.1365-2133.2010.09830.x


Related references

Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. Journal of Biological Chemistry 265(29): 17792-7, 1990

Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene. Pigment Cell Research Suppl 2: 96-100, 1992

A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type Ia) oculocutaneous albinism. Journal of Medical Genetics 28(7): 464-467, 1991

Mutation analysis of the tyrosinase gene in oculocutaneous albinism. Human Mutation 17(4): 352, 2001

Molecular analyses of the tyrosinase gene in patients with tyrosinase deficient oculocutaneous albinism. American Journal of Human Genetics 45(4 SUPPL): A221, 1989

Molecular studies of the tyrosinase gene in patients with type ia tyrosinase negative oculocutaneous albinism. American Journal of Human Genetics 43(3 SUPPL): A202, 1988

Molecular analysis of the Dna segments cross-hybridizable to the tyrosinase gene in patients affected with oculocutaneous albinism. The Tohoku Journal of Experimental Medicine 159(4): 333-340, 1989

Molecular analysis of the dna segments cross hybridizable to the tyrosinase gene in patients affects with oculocutaneous albinism. Tohoku Journal of Experimental Medicine 159(4): 333-340, 1989

Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients. Zhongguo Ying Yong Sheng Li Xue Za Zhi 27(3): 329-332, 2013

Molecular basis of type I (tryrosinase-related) oculocutaneous albinism: Mutations and polymorphisms of the human tyrosinase gene. Human Mutation 2(1): 1-6, 1993

Five novel mutations in tyrosinase gene of Japanese and Indian patients with oculocutaneous albinism type I (OCA1). Journal of Investigative Dermatology 125(2): 397-398, 2005

A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. Proceedings of the National Academy of Sciences of the United States of America 87(9): 3255-3258, 1990

A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. American Journal of Human Genetics 52(1): 17-23, 1993

Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism. American Journal of Human Genetics 48(2): 318-324, 1991

A nonsense mutation in the tyrosine gene of afghan patients with tyrosinase negative type ia oculocutaneous albinism. Journal of Medical Genetics 28(7): 464-467, 1991